| Serial Number | 90736220 |
| Word Mark | LINQURE |
| Filing Date | Wednesday, May 26, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 7, 2024 |
| Registration Number | 7376828 |
| Registration Date | Tuesday, May 7, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 19, 2022 |
| Goods and Services | Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid based therapy, gene therapy, cell therapy, gene diagnosis and gene testing |
| Goods and Services | Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy |
| Goods and Services | Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 20, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 20, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 20, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | uniQure IP B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BP NL |
| Party Name | uniQure IP B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BP NL |
| Party Name | uniQure IP B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BP NL |
| Event Date | Event Description |
| Saturday, May 29, 2021 | NEW APPLICATION ENTERED |
| Friday, August 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 8, 2022 | ASSIGNED TO EXAMINER |
| Thursday, February 10, 2022 | SUSPENSION LETTER WRITTEN |
| Thursday, February 10, 2022 | LETTER OF SUSPENSION E-MAILED |
| Thursday, February 10, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Sunday, May 22, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sunday, May 22, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sunday, May 22, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Sunday, May 22, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, May 22, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Saturday, May 28, 2022 | ASSIGNED TO LIE |
| Tuesday, May 31, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, May 31, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 31, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 13, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 29, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 19, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 19, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, July 20, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, July 20, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, July 20, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, July 20, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, August 18, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Thursday, January 12, 2023 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Wednesday, January 25, 2023 | ASSIGNED TO PETITION STAFF |
| Thursday, January 26, 2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Friday, January 27, 2023 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Tuesday, May 7, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 7, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |